Obesity-associated cancer may be driven by the high levels of insulin and insulin-related growth factors, the chronic inflammatory environment or in the case of breast and ovarian cancers, by the fact the adipose tissue produces oestrogen, which can stimulate abnormal cell growth. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.